Amuvatinib (MP-470)

Suppliers

Names

[ CAS No. ]:
850879-09-3

[ Name ]:
Amuvatinib (MP-470)

[Synonym ]:
Amuvatinib (MP-470)
MP470,MP-470
Amuvatinib
4-benzo[4,5]furo[3,2-d]pyrimidin-4-yl-piperazine-1-carbothioic acid (benzo[1,3]dioxol-5-ylmethyl)-amide
N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide
Amuvatinib (MP-470,HPK 56)
N-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(benzofuro[3,2-d]pyrimidin-4-yl)piperazine-1-carbothioamide
HPK56
MP 470
S1244_Selleck
N-(1,3-Benzodioxol-5-ylmethyl)-4-([1]benzofuro[3,2-d]pyrimidin-4-yl)-1-piperazinecarbothioamide
1-Piperazinecarbothioamide, N-(1,3-benzodioxol-5-ylmethyl)-4-(benzofuro[3,2-d]pyrimidin-4-yl)-

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
649.5±65.0 °C at 760 mmHg

[ Molecular Formula ]:
C23H21N5O3S

[ Molecular Weight ]:
447.509

[ Flash Point ]:
346.6±34.3 °C

[ Exact Mass ]:
447.136505

[ PSA ]:
115.02000

[ LogP ]:
2.79

[ Vapour Pressure ]:
0.0±1.9 mmHg at 25°C

[ Index of Refraction ]:
1.739

[ Storage condition ]:
-20°C

Synthetic Route

Precursor & DownStream

Precursor

  • 4-(1-Piperazinyl)[1]benzofuro[3,2-d]pyrimidine

DownStream


Related Compounds

  • Amuvatinib hydrochloride
  • XMU MP 1
  • LEWATIT MP-62
  • microperoxidase (mp-11) sodium salt
  • QuadraSil® MP
  • Ioglucomide
  • 1-(Difluoromethyl)-5-iodopyridin-2(1H)-one
  • 2-Chloro-5-(difluoromethoxy)-1-methyl-3-nitrobenzene
  • 4-bromo-3,5-dicyclopropyl-1H-pyrazole
  • 1-(4-Acetyl-1-piperazinyl)-3-[[2-amino-6-(4-fluorophenyl)pyrido[3,2-d]pyrimidin-4-yl]amino]-1-propanone
  • 1-Chloro-2-fluoro-3-prop-2-ynoxybenzene
  • Methyl 2-amino-2-(5,6,7,8-tetrahydronaphthalen-2-yl)acetate
  • N-(2-aminopropyl)-N-methylcyclobutanamine
  • 3-(2,4-dichlorophenyl)-5-methyl-1H-pyrazole
  • 3-(3-fluorophenyl)-5-methyl-1H-pyrazole
  • 4-Bromo-3-(4-bromophenyl)-5-methyl-1H-pyrazole
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.